Seeing Is Believing
Currently out of the existing stock ratings of Nadine Sarwat, 21 are a BUY (44.68%), 23 are a HOLD (48.94%), 3 are a SELL (6.38%).
Analyst Nadine Sarwat, currently employed at BERNSTEIN, carries an average stock price target met ratio of 55.01% that have a potential upside of 18.11% achieved within 91 days.
Nadine Sarwat’s has documented 93 price targets and ratings displayed on 8 stocks. The coverage is on Consumer Defensive, Healthcare sectors.
Most recent stock forecast was given on TLRY, Tilray at 25-Jun-2026.
Analyst best performing recommendations are on CRON (CRONOS GROUP).
The best stock recommendation documented was for CRON (CRONOS GROUP) at 11/1/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.23 (7.12%) receiving and performance score of 71.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-Aug-2025
$3.3
23 days ago
(07-Oct-2026)
4/6 (66.67%)
$0.15 (4.76%)
733
Sell Since 14-May-2026
$2.9
$-0.33 (-10.22%)
$2.65
5 months 16 days ago
(14-May-2026)
2/5 (40%)
$-0.25 (-7.94%)
129
Hold Since 09-May-2024
$3.5
$0.27 (8.36%)
$3
5 months 24 days ago
(06-May-2026)
5/14 (35.71%)
$0.07 (2.04%)
322
Hold Since 06-May-2026
$3.73
$0.43 (13.03%)
$2.88
5 months 24 days ago
(06-May-2026)
3/7 (42.86%)
$0.33 (9.71%)
178
Sell Since 11-Nov-2025
$1.95
$-1.35 (-40.91%)
$2.6
11 months 19 days ago
(11-Nov-2025)
1/2 (50%)
$-0.43 (-18.07%)
677
Which stock is Nadine Sarwat most bullish on?
Which stock is Nadine Sarwat most reserved on?
What Year was the first public recommendation made by Nadine Sarwat?